• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Veloxis Pharmaceuticals A/S

+ Add to Watchlist

VELO:DC

1.1700 DKK 0.0400 3.31%

As of 11:01:58 ET on 12/19/2014.

Snapshot for Veloxis Pharmaceuticals A/S (VELO)

Open: 1.2100 Day's Range: 1.1500 - 1.2200 Volume: 1,428,448
Previous Close: 1.2100 52wk Range: 0.6400 - 2.3000 1-Yr Rtn: +72.06%

Stock Chart for VELO

No chart data available.
  • VELO:DC 1.1700
  • 1D
  • 1M
  • 1Y
1.2100
Interactive VELO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VELO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. KFX -
Earnings Per Share (DKK) (ttm) -0.0049
Est. EPS (DKK) (12/2014) -0.0360
Est. PEG Ratio -
Market Cap (M DKK) 1,945.71
Shares Outstanding (M) 1,663.00
30 Day Average Volume 2,368,843
Price/Book (mrq) 6.4758
Price/Sale (ttm) 14.6910
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VELO

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for VELO

Veloxis Pharmaceuticals A/S is a specialty pharmaceutical company. The Company has numerous products in clinical stage and developed products, including a drug for immunosuppression, specifically organ transplantation, and products to combat certain cardiovascular diseases.

William J PolvinoPresident/CEOJohnny StilouExecutive VP/CFO
John D WeinbergExecutive VP/CCOChristina SylvestSVP:Global Clinical Dev&Operat
More Company Profile & Key Executives for VELO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil